These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 35235343)
1. DYRK1B-STAT3 Drives Cardiac Hypertrophy and Heart Failure by Impairing Mitochondrial Bioenergetics. Zhuang L; Jia K; Chen C; Li Z; Zhao J; Hu J; Zhang H; Fan Q; Huang C; Xie H; Lu L; Shen W; Ning G; Wang J; Zhang R; Chen K; Yan X Circulation; 2022 Mar; 145(11):829-846. PubMed ID: 35235343 [TBL] [Abstract][Full Text] [Related]
2. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction. Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656 [TBL] [Abstract][Full Text] [Related]
3. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152 [TBL] [Abstract][Full Text] [Related]
4. SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling. Yang D; Fan D; Guo Z; Liu FY; Wang MY; An P; Yang Z; Tang QZ J Am Heart Assoc; 2022 Nov; 11(22):e027004. PubMed ID: 36370010 [TBL] [Abstract][Full Text] [Related]
5. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses. Wende AR; Kim J; Holland WL; Wayment BE; O'Neill BT; Tuinei J; Brahma MK; Pepin ME; McCrory MA; Luptak I; Halade GV; Litwin SE; Abel ED Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1098-H1108. PubMed ID: 28822962 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB. Verma SK; Krishnamurthy P; Barefield D; Singh N; Gupta R; Lambers E; Thal M; Mackie A; Hoxha E; Ramirez V; Qin G; Sadayappan S; Ghosh AK; Kishore R Circulation; 2012 Jul; 126(4):418-29. PubMed ID: 22705886 [TBL] [Abstract][Full Text] [Related]
10. Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling. Gogiraju R; Hubert A; Fahrer J; Straub BK; Brandt M; Wenzel P; Münzel T; Konstantinides S; Hasenfuss G; Schäfer K Circ Heart Fail; 2019 Jan; 12(1):e005622. PubMed ID: 30621510 [TBL] [Abstract][Full Text] [Related]
11. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485 [TBL] [Abstract][Full Text] [Related]
12. TASK-1 and TASK-3 channels modulate pressure overload-induced cardiac remodeling and dysfunction. Duan W; Hicks J; Makara MA; Ilkayeva O; Abraham DM Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H566-H580. PubMed ID: 31977249 [TBL] [Abstract][Full Text] [Related]
13. Maintaining PGC-1α expression following pressure overload-induced cardiac hypertrophy preserves angiogenesis but not contractile or mitochondrial function. Pereira RO; Wende AR; Crum A; Hunter D; Olsen CD; Rawlings T; Riehle C; Ward WF; Abel ED FASEB J; 2014 Aug; 28(8):3691-702. PubMed ID: 24776744 [TBL] [Abstract][Full Text] [Related]
14. SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload. Wu G; Liu Y; Huang H; Tang Y; Liu W; Mei Y; Wan N; Liu X; Huang C Cardiovasc Res; 2015 Jul; 107(2):203-15. PubMed ID: 26077624 [TBL] [Abstract][Full Text] [Related]
15. Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac Hypertrophy but Requires Mitochondrial Antiviral Signaling Protein for Signal Transductions and Energy Balance. Lin HB; Naito K; Oh Y; Farber G; Kanaan G; Valaperti A; Dawood F; Zhang L; Li GH; Smyth D; Moon M; Liu Y; Liang W; Rotstein B; Philpott DJ; Kim KH; Harper ME; Liu PP Circulation; 2020 Dec; 142(23):2240-2258. PubMed ID: 33070627 [TBL] [Abstract][Full Text] [Related]
16. Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes. You J; Yue Z; Chen S; Chen Y; Lu X; Zhang X; Shen P; Li J; Han Q; Li Z; Liu P Acta Physiol (Oxf); 2017 May; 220(1):58-71. PubMed ID: 27614093 [TBL] [Abstract][Full Text] [Related]
17. Novel PGC-1 Zhang B; Tan Y; Zhang Z; Feng P; Ding W; Wang Q; Liang H; Duan W; Wang X; Yu S; Liu J; Yi D; Sun Y; Yi W Oxid Med Cell Longev; 2020; 2020():9187065. PubMed ID: 33425220 [TBL] [Abstract][Full Text] [Related]